KaloBios (KBIO) Files For Bankruptcy After Ousting Shkreli – ValueWalk Premium
KaloBios Pharmctcls (KBIO)

KaloBios (KBIO) Files For Bankruptcy After Ousting Shkreli

KaloBios Pharmaceuticals filed for Chapter 11 bankruptcy Tuesday night, as first reported by ValueWalk, within two weeks of CEO Martin Shkreli’s arrest on securities fraud.

The drug maker’s latest move comes on the heels of its appeal of Nasdaq's decision to delist its shares.

KaloBios files for bankruptcy
KaloBios listed assets and liabilities in the range of $1 million to $10 million in a

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0